Cargando…

Potential of ATP5MG to Treat Metabolic Syndrome-Associated Cardiovascular Diseases

INTRODUCTION: Metabolic syndrome-associated cardiovascular disease (MetS-CVD) is a cluster of metabolism-immunity highly integrated diseases. Emerging evidence hints that mitochondrial energy metabolism may be involved in MetS-CVD development. The physiopathological role of ATP5MG, a subunit of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Lianyong, Zhou, Xinglu, Chen, Juan, Li, Xiangqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355403/ https://www.ncbi.nlm.nih.gov/pubmed/35935642 http://dx.doi.org/10.3389/fcvm.2022.921778

Ejemplares similares

Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
por: Yan, Tong, et al.
Publicado: (2022)

Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis
por: Li, Xiao, et al.
Publicado: (2021)

Vascular Senescence in Cardiovascular and Metabolic Diseases
por: Katsuumi, Goro, et al.
Publicado: (2018)

Editorial: Mitochondria, metabolism and cardiovascular diseases
por: Koga, Jun-ichiro, et al.
Publicado: (2022)

Sphingolipid metabolism and signaling in cardiovascular diseases
por: Borodzicz-Jażdżyk, Sonia, et al.
Publicado: (2022)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

Iron in Cardiovascular Disease: Challenges and Potentials
por: Li, Shizhen, et al.
Publicado: (2021)

Protective Potential of Maresins in Cardiovascular Diseases
por: Liu, Min, et al.
Publicado: (2022)

The therapeutic potential of sphingolipids for cardiovascular diseases
por: Ya'ar Bar, Sapir, et al.
Publicado: (2023)

Associations of ATP-Sensitive Potassium Channel’s Gene Polymorphisms With Type 2 Diabetes and Related Cardiovascular Phenotypes
por: Liu, Cheng, et al.
Publicado: (2022)

Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort
por: Zibaeenezhad, Mohammad Javad, et al.
Publicado: (2022)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Dynamic Changes of Metabolic Syndrome Alter the Risks of Cardiovascular Diseases and All-Cause Mortality: Evidence From a Prospective Cohort Study
por: He, Di, et al.
Publicado: (2021)

The role of m5C methyltransferases in cardiovascular diseases
por: Wang, Yan-Yue, et al.
Publicado: (2023)

Editorial: Metabolism Linking Immunity and Inflammatory Phenotypes in Cardiovascular Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Editorial: Crosstalk between lipid metabolism and ferroptosis in cardiovascular diseases
por: Liu, Yuliang, et al.
Publicado: (2023)

Circadian Rhythm of Cardiovascular Disease: The Potential of Chronotherapy With Aspirin
por: Buurma, Marleen, et al.
Publicado: (2019)

Exosomes in Cardiovascular Diseases: Pathological Potential of Nano-Messenger
por: Jadli, Anshul S., et al.
Publicado: (2021)

Short sleep duration associated with increased risk for new-onset cardiovascular diseases in individuals with metabolic syndromes: Evidence from the China Health and Retirement Longitudinal Study
por: Sun, Jiaxin, et al.
Publicado: (2022)

Case Report: Abnormal ECG and Pantalgia in a Patient With Guillain–Barré Syndrome
por: Cao, Xiangqi, et al.
Publicado: (2021)

Understanding the Causes and Implications of Endothelial Metabolic Variation in Cardiovascular Disease through Genome-Scale Metabolic Modeling
por: McGarrity, Sarah, et al.
Publicado: (2016)

Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
por: AlZaim, Ibrahim, et al.
Publicado: (2020)

Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease
por: Lu, Yingdong, et al.
Publicado: (2022)

Editorial: The regulatory role of metabolic organ-secreted factors in the development of cardiovascular diseases
por: You, Mei, et al.
Publicado: (2023)

The regulatory role of metabolic organ-secreted factors in the nonalcoholic fatty liver disease and cardiovascular disease
por: Qin, Li, et al.
Publicado: (2023)

Stem Cell-Derived Exosomes Potential Therapeutic Roles in Cardiovascular Diseases
por: Jayaraman, Selvaraj, et al.
Publicado: (2021)

Cardiovascular health and potential cardiovascular risk factors in young athletes
por: Grabitz, Carl, et al.
Publicado: (2023)

Gender discrepancies in predictors for newly onset cardiovascular events and metabolic syndrome in elderly patients from rural China
por: Yu, Shasha, et al.
Publicado: (2022)

Early atrial remodeling predicts the risk of cardiovascular events in patients with metabolic syndrome: a retrospective cohort study
por: Wali, Rohbaiz, et al.
Publicado: (2023)

Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
por: Chait, Alan, et al.
Publicado: (2020)

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes
por: Jin, Jing-Lu, et al.
Publicado: (2022)

Glycosylation of HDL-Associated Proteins and Its Implications in Cardiovascular Disease Diagnosis, Metabolism and Function
por: Romo, Eduardo Z., et al.
Publicado: (2022)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Emerging computational paradigms to address the complex role of gut microbial metabolism in cardiovascular diseases
por: Aminian-Dehkordi, Javad, et al.
Publicado: (2022)

Editorial: Decoding complexity: new insights into the cellular and molecular mechanisms of cardiovascular and metabolic diseases
por: Liu, Chia-Feng, et al.
Publicado: (2023)

Role of Catestatin in the Cardiovascular System and Metabolic Disorders
por: Zalewska, Ewa, et al.
Publicado: (2022)

The Association Between the Frequency of Annual Health Checks Participation and the Control of Cardiovascular Risk Factors
por: Lei, Li, et al.
Publicado: (2022)

Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases
por: Dagher, Olina, et al.
Publicado: (2021)

Association of Metabolic Syndrome With Long-Term Cardiovascular Risks and All-Cause Mortality in Elderly Patients With Obstructive Sleep Apnea
por: Liu, Lin, et al.
Publicado: (2022)

Roles of Ferroptosis in Cardiovascular Diseases
por: Guo, Yuting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_243akbpjdipvnm5qrvgm45mh4m